Boothbay Fund Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
Boothbay Fund Management's ABVX Position: Q3 2026 in Review
Boothbay Fund Management increased its Abivax (ABVX) stake by 2.4% in Q3 2026, buying an estimated $1.63M and bringing the position to 576,871 shares worth $57.1M. The position accounts for 0.91% of the portfolio, ranked #6.
Boothbay Fund Management first reported a position in ABVX in Q4 2024 and has held it in 8 quarters since. The position peaked at $75.1M in Q2 2026. 305 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Boothbay Fund Management held 576,871 shares of Abivax worth $57.1M as of Q3 2026.
- Boothbay Fund Management bought 13,504 Abivax shares in Q3 2026, an estimated $1.63M.
- Abivax made up 0.91% of Boothbay Fund Management's portfolio in Q3 2026, its #6 holding.
- Boothbay Fund Management first reported a position in Abivax in Q4 2024 and has held it in 8 quarters since.
- Boothbay Fund Management's Abivax position peaked at $75.1M in Q2 2026.
- 305 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.